Prsentation PowerPoint - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

Prsentation PowerPoint

Description:

das Na es Unidas, 12.559 - CEP 04578-905 - S o Paulo - SP - Brazil ... Congress Chairmen & Program Committee. Scientific Committee. Fausto Feres ... – PowerPoint PPT presentation

Number of Views:22
Avg rating:3.0/5.0
Slides: 18
Provided by: eduar8
Category:

less

Transcript and Presenter's Notes

Title: Prsentation PowerPoint


1
International Cardiology, Metabolismand
Thrombosis Congress(ICMTC)
January 20-23, 2010 São Paulo, Brazil
A crossroad for clinical and practical
exchanges among different specialists
Held under the auspices of
2
Congress Venue
WTC Convention Center Av. das Nações Unidas,
12.559 - CEP 04578-905 - São Paulo - SP -
Brazil Telephone (55-11) 3055.8000 - Fax.
(55-11) 3055.8001 - E-mail hotel_at_wtchotel.com.br
3
Why attending ICMTC?
  • International prominent experts from several
    therapeutic areas
  • A state of the art for exchanges between
    different specialists
  • cardiologists,
  • diabetologists,
  • internists,
  • emergency physicians,
  • anesthesiologists,
  • nephrologists
  • On top of high quality plenary lectures a focus
    on clinical cases (Clinical Corners) and clinical
    skills training (Practical Corners)

A most stimulating, interdisciplinary
and must-attend congress for all physicians
caring for their cardio and vascular patients
4
Committees (1)
5
Committees (1)
Faculty (tentative)
6
Timetable
7
Preliminary Scientific Program (1) Committees (2)
  • Diabetes
  • Management of cardiovascular risk in diabetes
  • How to evaluate the risk of CHD in diabetic
    patients (epidemiology, clinical scores, imaging)
  • How to prevent CVD in diabetics (lipids, blood
    pressure, anti-platelets, glucose control)
  • Challenges in obesity and metabolic syndrome
    treatment and cardiovascular disease prevention
  • Prognostic significance of the change in glucose
    level in acute myocardial infarction
  • Therapeutics
  • Controversies on the use of TZD and
    cardiovascular risk in diabetics
  • New therapies for diabetes control and their
    implications in cardiovascular risk (GLP-1
    analogs and DPP4 inhibitors)
  • Intensive glucose control and cardiovascular
    disease prevention friend or foe?
  • Cardiology and Atherothrombosis (1)
  • Dyslipidemia debates
  • Cholesterol lowering and risk of cancer - fact or
    fiction?
  • Use of imaging and inflammatory markers for CHD
    risk stratification whats next after the MESA
    and JUPITER studies?
  • The importance of non-HDL cholesterol, HDL and
    Apolipoprotein B for CHD risk evaluation in both
    primary and secondary prevention beyond LDL for
    risk stratification

8
Preliminary Scientific Program (2) Committees (2)
  • Cardiology and Atherothrombosis (2)
  • Anti-thrombotic therapy
  • New advances in anti-thrombotic therapy for ACS
    plasugrel, clopidogrel dosages, bivaruldin, newer
    anti-thrombin drugs
  • Newer anti-thrombotic therapies for chronic
    patients, are they better than the old warfarin?
  • Is heparin the best medication for ACS patients?
  • Controversies in antiplatelet medications and
    primary cardiovascular prevention current
    guidelines, aspirin resistance, gender, diabetes,
    hypertension
  • Recent advances in Stenting
  • Controversies on the use of drug eluting stents
    do we still have to worry of late thrombosis?
  • Can stents be used as a safe alternative to
    surgery for carotid disease?
  • Are newer pharmacological stents better than
    older ones?
  • Revascularization procedures in diabetic patients
    - which is better stents or CABG?
  • Advances in Coronary Heart Disease
  • State of the art of STE myocardial infarction
    treatment
  • New recommendations for NSTE acute coronary
    syndrome
  • Treatment update of stable angina
  • Two years after the COURAGE study - is medical
    treatment a valid option for stable CHD patients?
  • MISSION LIFELINE Improving the System of Care
    for ST-elevation myocardial infarction patients
    (STEMI Chain of Survival)

9
Sponsorship Opportunities Levels
  • Sponsorship Opportunities
  • Satellite Symposia
  • Lunch or Breakfast Debates
  • Branding of Lunches, Coffee Breaks, Clinical
    Practical Corners
  • Branding of Cyber Cafés, Lounge, Relaxation area,
    Poster Area, Preview Area
  • Exhibition booth
  • Registration of Industry invited physicians
  • Company branded doctors bag, block-note
  • Inserts of product reminder card, leaflets,
    brochure, publication or reprint, CD-Rom, etc.

Sponsorship Levels
Diamond
Platinum
Platinum
Gold
Gold
Gold
Silver
Silver
Silver
Bronze
Bronze
Bronze
10
Exhibition Floorplan
7
8
9
4
1
5
2
6
3
10
11
12
TOTAL DE 12 STANDS E ÁREA TOTAL 308,00m2
11
Diamond Sponsor
VAT excluded
Currency exchange rate from June 10, 2009
12
Platinum Sponsor
VAT excluded
Currency exchange rate from June 10, 2009
13
Gold Sponsor
VAT excluded
Currency exchange rate from June 10, 2009
14
Silver Sponsor
VAT excluded
Currency exchange rate from June 10, 2009
15
Bronze Sponsor
VAT excluded
Currency exchange rate from June 10, 2009
16
Other Marketing Opportunities
Exchange rate June 10, 2009. FREE insert of a
brochure or a publication or a CD-ROM For 1
element ordered, we offer you the possibility to
insert FREE a company branded pen, for 2 ordered
elements, 20 rebate on the overall price, for 3
ordered elements, 30 rebate on the overall price.
17
Who to contact?
Mr. Eduard Otte Medical Director Discovery
Cascade Paris, France Email eduard.otte_at_discovery
-cascade.com
Mrs. Alexandra Quetard Public Relations
Manager Discovery Cascade Paris, France Email
alexandra.quetard_at_discovery-cascade.com
Informações no Brasil - Sociedade de Cardiologia
do Estado de São Paulo Ana Paula Fantin Telefone
(11) 3179-0039 e-mail anapaula_at_socesp.org.br Ende
reço Av Paulista, 2073 Edif Horsa I 15º andar
sala 1511 - CEP 01311-940 São Paulo - SP
Write a Comment
User Comments (0)
About PowerShow.com